Found: 73
Select item for more details and to access through your institution.
Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1342346
- By:
- Publication type:
- Article
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1261575
- By:
- Publication type:
- Article
Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
- Published in:
- Neurogastroenterology & Motility, 2023, v. 35, n. 7, p. 1, doi. 10.1111/nmo.14536
- By:
- Publication type:
- Article
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 3, p. 393, doi. 10.1007/s10120-023-01364-7
- By:
- Publication type:
- Article
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 391, doi. 10.1007/s11523-023-00962-w
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1514, doi. 10.1038/s41416-023-02193-2
- By:
- Publication type:
- Article
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 3, p. 1026, doi. 10.1111/cas.15650
- By:
- Publication type:
- Article
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
- Published in:
- Theranostics, 2023, v. 13, n. 2, p. 621, doi. 10.7150/thno.72297
- By:
- Publication type:
- Article
ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8606, doi. 10.1245/s10434-022-12102-1
- By:
- Publication type:
- Article
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.932212
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 426, doi. 10.1159/000525582
- By:
- Publication type:
- Article
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 5, p. 451, doi. 10.1159/000525489
- By:
- Publication type:
- Article
Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 741, doi. 10.1007/s10120-022-01301-0
- By:
- Publication type:
- Article
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221087555
- By:
- Publication type:
- Article
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00356-6
- By:
- Publication type:
- Article
Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 141, doi. 10.1007/s11523-022-00867-0
- By:
- Publication type:
- Article
Disruption of Her2-Induced PD-L1 Inhibits Tumor Cell Immune Evasion in Patient-Derived Gastric Cancer Organoids.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6158, doi. 10.3390/cancers13246158
- By:
- Publication type:
- Article
Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 169, doi. 10.1002/ijc.33534
- By:
- Publication type:
- Article
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 3, p. 611, doi. 10.1007/s10120-020-01151-8
- By:
- Publication type:
- Article
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 192, doi. 10.1159/000512000
- By:
- Publication type:
- Article
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 961, doi. 10.1007/s10120-020-01079-z
- By:
- Publication type:
- Article
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1599, doi. 10.3390/cancers12061599
- By:
- Publication type:
- Article
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10127-x
- By:
- Publication type:
- Article
FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 836, doi. 10.3390/cancers11060836
- By:
- Publication type:
- Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
- By:
- Publication type:
- Article
Predictors of survival outcome following radical gastrectomy for gastric cancer.
- Published in:
- ANZ Journal of Surgery, 2019, v. 89, n. 1/2, p. 84, doi. 10.1111/ans.15011
- By:
- Publication type:
- Article
A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nimbolide in Mouse Serum: Application to a Preclinical Pharmacokinetics Study.
- Published in:
- Pharmaceutics, 2018, v. 10, n. 3, p. 123, doi. 10.3390/pharmaceutics10030123
- By:
- Publication type:
- Article
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30686-1
- By:
- Publication type:
- Article
Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 9, p. 1890, doi. 10.1002/ijc.31091
- By:
- Publication type:
- Article
Resisting resistance to cancer immunotherapy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 5, p. 507, doi. 10.1111/1759-7714.12614
- By:
- Publication type:
- Article
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 43, doi. 10.1111/cas.13424
- By:
- Publication type:
- Article
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 5, p. 605, doi. 10.1007/s00262-017-1969-z
- By:
- Publication type:
- Article
Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.
- Published in:
- Gastric Cancer, 2017, v. 20, p. 122, doi. 10.1007/s10120-016-0660-y
- By:
- Publication type:
- Article
Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 2, p. 751, doi. 10.1002/mc.22532
- By:
- Publication type:
- Article
Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells.
- Published in:
- BMC Genomics, 2016, v. 17, p. 87, doi. 10.1186/s12864-016-3322-x
- By:
- Publication type:
- Article
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Identification of Gastric Cancer Biomarkers Using <sup>1</sup>H Nuclear Magnetic Resonance Spectrometry.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162222
- By:
- Publication type:
- Article
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours.
- Published in:
- Scientific Reports, 2016, p. 27826, doi. 10.1038/srep27826
- By:
- Publication type:
- Article
Dose modifications in Asian cancer patients with hepatic dysfunction receiving weekly docetaxel: A prospective pharmacokinetic and safety study.
- Published in:
- Cancer Science, 2016, v. 107, n. 2, p. 173, doi. 10.1111/cas.12856
- By:
- Publication type:
- Article
Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147681
- By:
- Publication type:
- Article
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1550-0
- By:
- Publication type:
- Article
GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 550, doi. 10.1186/s12885-015-1550-0
- By:
- Publication type:
- Article
An integrative approach identified genes associated with drug response in gastric cancer.
- Published in:
- Carcinogenesis, 2015, v. 36, n. 4, p. 441, doi. 10.1093/carcin/bgv014
- By:
- Publication type:
- Article